MIF and neoplasm: Despite its overexpression in malignant tissues, no significant differences in MIF levels or promoter allele frequencies (-794CATT5–7) correlate with tumor differentiation grade (well/moderate/poor) or clinical stage (I/II vs. III/IV) (217, 222).